• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Equity of the Meningitis B vaccination programme in England, 2016-2018
Vaccine. 2022 Sep 15:S0264-410X(22)01111-2. doi: 10.1016/j.vaccine.2022.09.023. Online ahead of print.ABSTRACTIn England, the Meningitis B (MenB) vaccine is scheduled at eight and 16 weeks with a booster dose at one year of age and protects children against invasive bacterial meningococcal disease caused by Neisseria meningitidis serogroup B. Coverage of the second dose of MenB vaccine at 12 months was >92% in 2017/18, but this may mask inequalities in coverage in particular population groups. MenB vaccination records for children aged six, 12 and 18 months of age from December 2016 to May 2018 were routinely extracted ...
Source: Vaccine - September 18, 2022 Category: Allergy & Immunology Authors: Karen S Tiley Joanne M White Nick Andrews Elise Tessier Michael Edelstein Source Type: research

Does social deprivation correlate with meningococcal MenACWY, Hib/MenC and 4CMenB/Meningococcal Group B vaccine uptake in Northern Ireland?
CONCLUSIONS: Within the last two decades, incidence of meningococcal disease has been on the decline. The introduction of meningococcal vaccines has contributed to this decrease and uptake of such vaccines should remain a public health priority to maintain the decline in meningococcal disease. Identifying contributing factors to low vaccine uptake, such as, the association between local deprivation and uptake of meningococcal vaccines, should be of public health importance and acknowledged by local governments and policy makers in their efforts to enhance vaccine uptake, both infant and teenage vaccination. There is a clea...
Source: The Ulster Medical Journal - February 16, 2022 Category: General Medicine Authors: Orlaith C Brennan John E Moore Beverley C Millar Source Type: research

Pages: 1  2  3  4  5  6  7